Help us: Donate
Follow us on:
×

Tag: Immune system

March 27, 2020
The World Health Organization has initiated a trial to test four treatments that may be effective against the global pandemic of COVID-19. The COVID-19 pandemic has swept around the globe, shutting down cities and bringing countries to a standstill as governments scramble to control its spread. Though many researchers are racing to develop a vaccine...
January 14, 2020
Everyone is different, and that certainly applies to aging, according to new research that drills down into how people age as individuals rather than looking at population averages.  Everyone ages differently In a new study, researchers at Stanford University School of Medicine have managed to sort people into different categories based on how they are...
June 26, 2019
Today, we want to highlight a new publication that looks at cytomegalovirus (CMV) and its potential role in the development of metabolic syndrome. What is cytomegalovirus?  CMV is part of the β-subfamily of herpes viruses, a family of viruses that are believed to have been co-evolving with their hosts for around 180 million years [1]....
May 24, 2019
A recent study has outlined the relationship between B cells, atherosclerosis, and the transcription factor c-Myb. While this factor is necessary for hematopoiesis, the formation of new blood cells, it has been shown to affect B cells, a type of lymphocyte, in a way that makes atherosclerosis more severe. A new look at inflammaging Inflammation...
March 26, 2019
A new review discusses how neutrophils release toxic substances into the body under inflammatory conditions, detailing one of the ways in which chronic inflammation causes long-term damage. Casting a deadly NET As we age, we suffer from the ever-increasing chronic inflammation known as inflammaging. This persistent, smoldering background of low-grade inflammation harms wound healing and...
March 19, 2019
Last year, resTORbio announced the positive results of its phase 2b human trial, which targeted the aging immune system with an immune system-boosting drug. Now, the company has announced the news that its therapy is moving to a phase 3 study later this year after successful negotiation with the FDA. Targeting the mTOR pathway of...